Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to determine superiority of YHP1701 comparing to each monotherapy in patient with hypertension and primary hypercholesterolemia.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT03103256
Study type Interventional
Source Yuhan Corporation
Contact
Status Completed
Phase Phase 3
Start date May 17, 2017
Completion date April 30, 2018

See also
  Status Clinical Trial Phase
Active, not recruiting NCT05326386 - Gamification and Medication Adherence (GAME Adherence) N/A